U.S. Hospitality Stock News

EGFR Market Attention Puts Focus on ArriVent BioPharma Recent commentary on the EGFR inhibitor market, highlighting precision medicine trends and ArriVent BioPharma (AVBP) firmonertinib trials in non small cell lung cancer, has pushed this clinical stage stock back onto investor watchlists. See our latest analysis for ArriVent BioPharma. At a latest share price of US$30.30, ArriVent's short term share price return has been relatively steady. The 30 day share price return of 8.7% and year to...

Everest Group Ltd. recently appointed Peter Chalkias as Australia country head and chief financial officer, bringing expertise in financial risk, risk management, accounting, financial planning, and business process improvement to its expanding international operations. This leadership move underlines Everest Group’s intent to sharpen financial discipline and operational oversight in a key growth market for its reinsurance and insurance franchise. Next, we’ll explore how Chalkias’s...

People Inc. has submitted a major cash proposal to acquire NYSE:MGM and take the company private. The MGM board is formally reviewing the offer, signaling an active M&A process. Major insider He Chaolian has fully exited MGM, marking a complete sale of that insider stake. The proposal and insider exit together point to a significant shift in MGM's ownership structure and governance. MGM Resorts International, traded as NYSE:MGM, operates casinos, resorts and entertainment properties,...

Pathward Financial, Inc. recently declared a US$0.05 per-share cash dividend for its third fiscal quarter of 2026, payable on July 1 to shareholders of record as of June 11, and was previously named to Keefe, Bruyette & Woods’ 2026 Bank Honor Roll for consistent 10-year earnings and EPS growth. This combination of a continued dividend and recognition for long-term earnings consistency highlights how management is emphasizing both income returns and execution of its long-term plan. Next,...

BioCryst Pharmaceuticals (BCRX) drew investor attention after presenting new clinical and real world data on its hereditary angioedema therapies ORLADEYO and navenibart at the European Academy of Allergy and Clinical Immunology meeting in Istanbul. See our latest analysis for BioCryst Pharmaceuticals. At a share price of US$9.06, BioCryst has seen short term momentum pick up around the EAACI data, with a 1 day share price return of 4.14% and year to date share price return of 20.80%. However,...

Reverse stock split and governance changes at Marqeta Marqeta (MQ) shareholders have approved a 1-for-4 reverse stock split, a reduction in authorized common and preferred shares, and new officer exculpation provisions under Delaware law, reshaping both the capital structure and governance framework. See our latest analysis for Marqeta. Despite a modest 1-day share price return of 1.57% to US$3.89 and a slightly positive 30-day share price return of 2.10%, Marqeta’s year-to-date share price...

Eaton (ETN) has drawn investor attention after recent performance data showed a past 3 months total return of 11.85% and a 1 year total return of 21.82%, with shares last closing at US$407.06. See our latest analysis for Eaton. Recent trading has added to that picture, with a 4.00% 1 day share price return and an 11.85% 90 day share price return, alongside a 3 year total shareholder return of 121.26%. This suggests momentum has been building over both shorter and longer periods. If Eaton’s...

Strategy Inc (NasdaqGS:MSTR) is at the center of an intense debate over its Bitcoin treasury approach following recent Bitcoin transactions and fresh public commentary from Executive Chairman Michael Saylor. Saylor has addressed controversy around recent Bitcoin sales, distinguishing the company’s policies from his personal "never sell" phrase. Management has introduced new proprietary Bitcoin treasury metrics, including BPS, CEBE BPS, and Amplification, aimed at reframing discussions on...

Citizens recently upgraded EPR Properties (EPR) to Market Outperform, citing the company’s focus on experiential real estate investments, increased investment activity, and more stable theater operations as factors supporting a stronger long-term business profile. See our latest analysis for EPR Properties. The latest upgrade comes after a strong run in the share price, with a year to date share price return of 14.97% and a 3 year total shareholder return of 58.09%. This suggests momentum has...

In recent days, Compass has come under scrutiny after the New York Attorney General opened an antitrust investigation into its acquisition of Anywhere Real Estate, prompting a related securities probe by Pomerantz LLP and sparking heavy options trading activity. This combination of regulatory attention and legal risk is testing the resilience of Compass’s agent-centric, technology-driven brokerage model at a time when its profitability profile and commission-based revenue mix are already...

Vancouver Police Department has become the first police force in Canada to deploy Axon’s Skydio X10 drones. The rollout includes Axon Assistant’s real-time translation and Fleet 3 in-car video with automated recording features. The contract marks an extension of Axon’s public safety technology footprint outside its core U.S. market. For Axon Enterprise (NasdaqGS:AXON), this contract with Vancouver Police Department highlights how the company’s hardware and AI tools are being used together...

Ralph Lauren (RL) has been back in focus after first quarter 2026 results beat Wall Street expectations. In addition, falling oil prices improved the consumer spending backdrop, lifting the stock to a fresh 52 week high. See our latest analysis for Ralph Lauren. The recent first quarter earnings beat and easing energy costs have coincided with strong momentum, with a 30 day share price return of 26.18% and a 1 year total shareholder return of 54.33%. If this kind of consumer strength has your...

Inhibrx Biosciences recently reported that the U.S. FDA accepted for filing its Biologics License Application for ozekibart (INBRX-109) to treat unresectable or metastatic conventional chondrosarcoma, assigning a PDUFA goal date of April 14, 2027 and flagging no filing review issues at this stage. If approved, ozekibart would become the first FDA-approved treatment option for this aggressive bone cancer, addressing a significant unmet medical need highlighted by the positive ChonDRAgon trial...

Recent valuation concerns trigger Lincoln Electric move On June 10, 2026, Lincoln Electric Holdings (LECO) shares fell 4.6% after fresh commentary highlighted that the stock trades at a premium to its historical valuation and about 7.3% above estimated fair value. See our latest analysis for Lincoln Electric Holdings. Short term volatility around the June 10 pullback contrasts with steadier momentum, with a 1 month share price return of 2.66% and a 1 year total shareholder return of 32.78%...

Verizon Communications (NYSE:VZ) joined Anthropic's Project Glasswing, an AI focused cybersecurity collaboration, to help protect its communications infrastructure. The company received FCC approval to acquire US$1b in wireless spectrum from US Cellular for additional network capacity. Verizon Business expanded its partnership with Ericsson to offer private 5G networks to enterprises outside the U.S. For a large U.S. telecom operator such as Verizon Communications, core earnings power...

Bitdeer Technologies Group (BTDR) has begun construction on its Fox Creek facility in Alberta, where a 101 MW natural gas power plant will be paired with around 100 MW of computing capacity focused on Bitcoin mining and potential AI workloads. See our latest analysis for Bitdeer Technologies Group. Recent moves like the Fox Creek build and senior leadership changes sit against a strong backdrop, with a 30 day share price return of 37.23% and a 90 day share price return of 98.05% supporting a...

Recent Performance Snapshot THOR Industries (THO) has seen mixed share performance, with the stock down over the past year and year to date, but showing a gain over the past month and a decline over the past 3 months. At a recent close of US$75.98 and a market value of about US$4.0b, the company reports annual revenue of US$9.82b and net income of US$262.46m. See our latest analysis for THOR Industries. Recent trading shows momentum fading, with the share price down 27.93% year to date and...

Earlier in June 2026, AECOM entered into a new US$500 million revolving credit facility maturing in 2028, while its Board declared a US$0.31 per-share quarterly dividend payable on July 17, 2026. Separately, the U.S. Department of Homeland Security selected AECOM to continue providing architecture and engineering services for nationwide critical infrastructure modernization across all states and key territories, reinforcing the firm’s role in long-running federal facility upgrade...

Wondering whether Luckin Coffee at around US$30.56 now offers good value or fresh risk? This article breaks down what that current price may really imply for you. The stock is down about 0.2% over the past week, 4.5% over the past month, 13.7% year to date and 13.4% over the past year. The three year return sits at 36.4%, and the five year return is a very large gain. Recent coverage of Luckin Coffee has focused on its position as a growing coffee chain in China and the implications of...

Sprouts Farmers Market (SFM) is expanding its in store offerings through a new partnership with Tampa based Buddy Brew Coffee. The collaboration will bring 10 coffee cafes into select Florida locations starting June 17, 2026. See our latest analysis for Sprouts Farmers Market. While the latest Buddy Brew rollout is aimed at deepening the in store experience, Sprouts Farmers Market’s short term share price return has softened recently, with the 7 day share price return down 1.49% and the 90...

Aurora Innovation has recently attracted renewed attention after reporting Q1 2026 results that were slightly ahead of expectations, securing new positive analyst coverage, and seeing director David Wehner purchase 82,500 shares following earlier selling pressure from an Uber Technologies subsidiary. This combination of insider buying, analyst support, and continued progress toward deploying more than 200 driverless trucks by year-end has shifted focus back to Aurora’s autonomous trucking...

Bank of America (BAC) has been drawing investor attention after a period of strong multiyear total returns, prompting closer scrutiny of how its current share price, recent performance and fundamentals line up. See our latest analysis for Bank of America. Today’s share price of $55.87 sits against a mixed backdrop, with a 30 day share price return of 12.26% and a 1 year total shareholder return of 28.55% building on strong multiyear gains. If you are weighing Bank of America against other...

Palo Alto Networks (PANW) is back in focus after reporting fiscal third quarter earnings, pairing strong revenue growth with a quarterly net loss and issuing optimistic guidance that leans heavily on rising AI driven cybersecurity demand. See our latest analysis for Palo Alto Networks. The earnings beat and upbeat guidance have come alongside strong market interest, with a 68.18% 3 month share price return and a 360.25% 5 year total shareholder return suggesting momentum has been strong over...

High interest rates, rising oil prices and concerns around an AI-fueled bubble are making many investors rethink how much risk they really want in their portfolios. Instead of chasing the hottest stories, some are looking at larger companies that historically show calmer price swings and stronger balance sheets. This article focuses on three stocks from a low volatility screener that appear particularly exposed to these macro trends and could either help cushion the bumps or feel the strain...